Mr. Corey Giasson reports

MUSTGROW REPORTS SIGNIFICANT U.S. POTATO YIELD AND ECONOMIC PERFORMANCE IN LARGE SCALE FIELD TRIALS UTILIZING TERRASANTE(TM)

Mustgrow Biologics Corp. had outstanding performance metrics on its organic TerraSante biofertility product applied to potato farming acres in Washington State and Idaho, based on customer performance data.

• Mustard-derived organic TerraSante focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies;
• Large-scale field trial showed two-ton-per-acre yield increase with larger size potatoes and less culls equating to approximately $5,000 (U.S.) increase in value per acre;
• Significant soil health benefit when applied in combination with the current grower standard program.

In its use by a Washington State farming customer, TerraSante demonstrated a consistent and substantial potato yield, size, and quality increase at a dose rate of 11 pounds/acre. This customer performance data were generated on a large-scale commercial potato field. With the increase in size, quality and yield, the farmer estimated an approximate $5,000 (U.S.) increase in value per acre at a cost of only $180 (U.S.) per acre for TerraSante. Work done in fields in Idaho has also shown significant benefits to the soil and health of the potato crops when used within a currently established grower production program.

These large-scale field trial results are consistent with small plot results that Mustgrow has completed in the U.S. with TerraSante, as outlined in the attached table.

Mustgrow's mustard-derived TerraSante organic biofertilizer is a soluble mixable form containing nutritious plant proteins and carbohydrates that feed the soil and soil microbes. TerraSante is currently registered and approved for sale in California, Florida, Arizona, Idaho, Oregon and Washington State, under Organic OMRI Listed certification and California's Organic Input Material (OIM) program.

In 2024, the United States Department of Agriculture (USDA) reported 927,000 potato acres harvested for $4.6-billion (U.S.) of value sold.

TerraSante for soil and ecological health

Mustgrow's biofertility program focuses on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. Soil is a farmer's most valuable asset, and Mustgrow's mustard plant-based technologies are being applied with the intention to improve not only the health of the soil, but also the surrounding ecological environment.

TerraSante, an organic biofertilizer in soluble mixable form, contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially improving beneficial microbial activity and ensuring long-term sustainable soil health. These targeted microcommunities have been shown to work to improve nutrient availability, which can potentially increase plant vigor and yields, while reducing plant stress. TerraSante has the potential to improve crop nutrient uptake and, hence, overall crop performance. There are no artificial additives or preservatives used during its manufacturing.

About Mustgrow Biologics Corp.

Mustgrow Biologics is a fully integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The company's proprietary and third party product lines offer ecofriendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, Mustgrow offers a portfolio of third party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, adjuvants and foliar products. These products are synergistically distributed alongside Mustgrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, Mustgrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize Mustgrow's wholly owned proprietary products and technologies. The company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio of approximately 110 patents that are currently issued and pending, and the sales and distribution of its proprietary and third party product lines through NexusBioAg. Mustgrow is a publicly traded company and has approximately 58.9 million common shares issued and outstanding and 69.1 million shares fully diluted.

We seek Safe Harbor.